Siwen Hu-Lieskovan, MD, PhD

Associate Professor, Department of Medicine
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA, United States

Presentation(s):

• 57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations

  Friday, March 24, 2023
  10:24 AM – 10:34 AM

  Disclosure information not submitted.